Diabetes may modify the efficacy of primary prevention implantable cardioverter-defibrillators in non-ischemic systolic heart failure: an extended follow-up of the DANISH trial
26 August 2022 (08:00 - 19:30)
Organised by:
About the speaker
Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
5 More presentations in this session
Miss C. van der Hoef (Groningen, NL)
Mr E. Zweck (Duesseldorf, DE)
Doctor S. Yalamanchili (Greenville, US)
Access the full session
The Event
ESC Congress 2022
26 August - 29 August 2022
You may be interested in
Congress Presentation
Congress Session
